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j ourna l homepage: www.e lsev ie r.com/ locate /bbad isPreface: A special issue on nuclear receptors with a special view on the molecular
basis of diseaseThis special issue focuses on nuclear hormone receptors with a
direct view on their involvement in the pathophysiology of several
conditions. Indeed, nuclear receptors have been implicated in the
pathogenesis of highly frequent diseases such as metabolic syndrome
and various types of cancer. Furthermore, most of these 48 proteins
are intriguing pharmacological targets since we actually have in clinic
several molecules that directly modulate nuclear receptor transcrip-
tional activity as therapeutic strategies. We thus accepted the
invitation from the editors to dedicate an entire issue to this family
of transcription factors that regulate very important processes in our
organism ranging from development, metabolism, and reproduction.
Thus, a wide variety of conditions are described in this issue with a
multidisciplinary analysis. The reader will ﬁnd chapters that: a)
describe the physical–chemical structure of these proteins; b)
underline the importance of bioinformatics to discover novel
transcription targets of these receptors; c) present new methodolog-
ical studies on how to identify the function of these receptors in terms
of spatial and temporal distribution in our body. A series of chapters
will then describe the relevance of nuclear receptors in different type
of diseases. There are reviews on the importance of nuclear receptors
in cancer, ranging from hepatocellular to colorectal cancer and
hematopoietic malignancies. Other articles focus on the role of
nuclear receptors in the pathogenesis and/or treatment of metabolic
diseases such as metabolic syndrome, dyslipidemia, atherosclerosis
and diabetes. Finally, there are articles that underscore the function of
nuclear receptors and their co-regulators in neurological diseases
such as Parkinson, and in conditions affecting the reproductive system
and the urinary-kidney function.
The success of this issue will depend on its capacity to attract
colleagues who are not actually working on nuclear receptors and to
provide a space for discussion in the translational relevance of nuclear
receptor function in human disease. A lot of work has been done to
achieve this goal. A special thanks goes ﬁrst to all the authors for their
important contributions. Then, we thank the reviewers, who did a
patient and superb job in helping and increasing the quality of the
ﬁnal manuscripts. Finally, we express our gratitude to the editorial0925-4439/$ – see front matter © 2011 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2011.05.009ofﬁce for the everyday unique support to generate this issue. We hope
you enjoy reading this issue and you get intriguing ideas for your
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tract. The group aims at investigating how nuclear
receptors could transcriptionally link the metabolism ofglucose and lipids with the initiation and/or progression of the cancer progress in the
intestinal epithelium. His speciﬁc strategy is to identify the interconnection of
transcriptional and metabolic pathways in the gut–liver axis with relevance to
systemic disease such as metabolic syndrome and cancer. His latest focus is on how
nutrients could activate and/or inhibit nuclear receptor transcriptional activity, thus
linking diet to DNA. His group is looking for designing novel gene expression maps
that could predict the relationship between nutrients and evolution of cancer. The ﬁnal
hope is that clustering the genes that depict the invasive picture of certain tumors or
the increased cardiovascular risks of speciﬁc subjects would lead to a better molecular
understanding of the pathogenesis and in the future more effective ad personam
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